GSK-208109/231

Study Sponsor: GSK

Study Title

Immunogenicity & Safety of GSK Biologicals' Inactivated Hepatitis A Vaccine (Havrix™) Co-administered With Merck & Company, Inc. Measles-Mumps-Rubella Vaccine (M-M-RII) & Merck & Co Varicella Vaccine (VARIVAX™) to Children 15 Months of Age

Medicine or Vaccine (generic name)

Hepatitis A Vaccine, Inactivated

Sponsor Identification Number

208109/231

Trial Registry Identification Number(#'s)

NCT00197015 2015-001509-15

Medical Condition

Hepatitis A

Phase

Phase 3

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=208109/231

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00197015

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2015-001509-15

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

An annotated case report form is not available for this study. A blank case report form will be provided.

Date Added to this Site

February 2015